Inari Ebitda vs Selling And Marketing Expenses Analysis

NARI Stock

USD 50.00 0.69 1.36%

Inari MedicalInc financial indicator trend analysis is infinitely more than just investigating Inari MedicalInc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inari MedicalInc is a good investment. Please check the relationship between Inari MedicalInc Ebitda and its Selling And Marketing Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari MedicalInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari MedicalInc guide.

Ebitda vs Selling And Marketing Expenses

Ebitda vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inari MedicalInc Ebitda account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have weak relationship.

The correlation between Inari MedicalInc's Ebitda and Selling And Marketing Expenses is 0.38. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Inari MedicalInc, assuming nothing else is changed. The correlation between historical values of Inari MedicalInc's Ebitda and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Inari MedicalInc are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Ebitda i.e., Inari MedicalInc's Ebitda and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.38

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Ebitda

Selling And Marketing Expenses

Most indicators from Inari MedicalInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inari MedicalInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari MedicalInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari MedicalInc guide.As of now, Inari MedicalInc's Tax Provision is increasing as compared to previous years. The Inari MedicalInc's current Sales General And Administrative To Revenue is estimated to increase to 0.94, while Selling General Administrative is projected to decrease to under 176.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	252.2M	339.0M	428.8M	219.5M
Total Revenue	277.0M	383.5M	493.6M	247.8M

Gross Profit Total Revenue

Inari MedicalInc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.86	0.99	0.99	0.99	0.99	0.87	-0.12	-0.3	0.92	0.53	0.9	0.85	0.47	0.74	0.75	0.92	0.82	0.93	0.74	0.46	0.94	1.0	0.89	0.92	0.81
Short Long Term Debt Total	0.86		0.84	0.85	0.91	0.91	0.87	-0.49	0.08	0.92	0.79	0.62	0.76	0.72	0.95	0.87	0.94	0.96	0.95	0.95	0.03	0.95	0.86	0.91	0.93	0.46
Other Current Liab	0.99	0.84		1.0	0.97	0.98	0.9	-0.05	-0.29	0.93	0.49	0.9	0.86	0.49	0.74	0.73	0.92	0.8	0.94	0.74	0.49	0.92	1.0	0.9	0.9	0.83
Total Current Liabilities	0.99	0.85	1.0		0.97	0.98	0.9	-0.06	-0.28	0.93	0.5	0.9	0.86	0.5	0.74	0.73	0.92	0.8	0.94	0.74	0.48	0.92	1.0	0.9	0.9	0.83
Total Stockholder Equity	0.99	0.91	0.97	0.97		1.0	0.89	-0.25	-0.2	0.92	0.64	0.83	0.8	0.49	0.78	0.83	0.95	0.88	0.95	0.78	0.32	0.97	0.98	0.92	0.95	0.71
Net Tangible Assets	0.99	0.91	0.98	0.98	1.0		0.89	-0.24	-0.21	0.92	0.63	0.84	0.8	0.49	0.78	0.82	0.95	0.88	0.95	0.78	0.33	0.97	0.99	0.92	0.95	0.72
Property Plant And Equipment Net	0.87	0.87	0.9	0.9	0.89	0.89		-0.17	-0.05	0.96	0.52	0.66	0.66	0.43	0.78	0.84	0.96	0.87	0.88	0.78	0.17	0.87	0.89	0.97	0.94	0.58
Net Debt	-0.12	-0.49	-0.05	-0.06	-0.25	-0.24	-0.17		-0.72	-0.18	-0.88	0.15	-0.01	-0.31	-0.44	-0.48	-0.27	-0.57	-0.35	-0.44	0.68	-0.44	-0.08	-0.33	-0.31	0.41
Retained Earnings	-0.3	0.08	-0.29	-0.28	-0.2	-0.21	-0.05	-0.72		-0.11	0.52	-0.47	-0.26	0.14	0.11	0.06	-0.1	0.18	0.02	0.11	-0.71	0.03	-0.3	0.06	-0.12	-0.6
Accounts Payable	0.92	0.92	0.93	0.93	0.92	0.92	0.96	-0.18	-0.11		0.54	0.76	0.8	0.55	0.87	0.77	0.99	0.91	0.93	0.87	0.29	0.9	0.92	0.97	0.96	0.67
Cash	0.53	0.79	0.49	0.5	0.64	0.63	0.52	-0.88	0.52	0.54		0.26	0.41	0.54	0.69	0.74	0.61	0.81	0.72	0.69	-0.37	0.79	0.51	0.66	0.62	0.02
Non Current Assets Total	0.9	0.62	0.9	0.9	0.83	0.84	0.66	0.15	-0.47	0.76	0.26		0.88	0.36	0.54	0.39	0.73	0.57	0.79	0.54	0.77	0.75	0.9	0.69	0.7	0.96
Non Currrent Assets Other	0.85	0.76	0.86	0.86	0.8	0.8	0.66	-0.01	-0.26	0.8	0.41	0.88		0.75	0.79	0.44	0.76	0.63	0.87	0.79	0.61	0.76	0.85	0.69	0.69	0.83
Other Assets	0.47	0.72	0.49	0.5	0.49	0.49	0.43	-0.31	0.14	0.55	0.54	0.36	0.75		0.84	0.45	0.53	0.51	0.67	0.84	0.06	0.55	0.49	0.45	0.45	0.3
Long Term Debt	0.74	0.95	0.74	0.74	0.78	0.78	0.78	-0.44	0.11	0.87	0.69	0.54	0.79	0.84		0.73	0.88	0.87	0.88	1.0	0.04	0.83	0.74	0.82	0.83	0.41
Cash And Short Term Investments	0.75	0.87	0.73	0.73	0.83	0.82	0.84	-0.48	0.06	0.77	0.74	0.39	0.44	0.45	0.73		0.84	0.86	0.77	0.73	-0.21	0.85	0.74	0.83	0.86	0.25
Net Receivables	0.92	0.94	0.92	0.92	0.95	0.95	0.96	-0.27	-0.1	0.99	0.61	0.73	0.76	0.53	0.88	0.84		0.94	0.93	0.88	0.2	0.93	0.92	0.97	0.99	0.61
Common Stock Total Equity	0.82	0.96	0.8	0.8	0.88	0.88	0.87	-0.57	0.18	0.91	0.81	0.57	0.63	0.51	0.87	0.86	0.94		0.9	0.87	-0.06	0.94	0.81	0.95	0.95	0.38
Common Stock Shares Outstanding	0.93	0.95	0.94	0.94	0.95	0.95	0.88	-0.35	0.02	0.93	0.72	0.79	0.87	0.67	0.88	0.77	0.93	0.9		0.88	0.27	0.97	0.94	0.93	0.9	0.66
Long Term Debt Total	0.74	0.95	0.74	0.74	0.78	0.78	0.78	-0.44	0.11	0.87	0.69	0.54	0.79	0.84	1.0	0.73	0.88	0.87	0.88		0.04	0.83	0.74	0.82	0.83	0.41
Non Current Liabilities Total	0.46	0.03	0.49	0.48	0.32	0.33	0.17	0.68	-0.71	0.29	-0.37	0.77	0.61	0.06	0.04	-0.21	0.2	-0.06	0.27	0.04		0.16	0.47	0.14	0.16	0.89
Capital Surpluse	0.94	0.95	0.92	0.92	0.97	0.97	0.87	-0.44	0.03	0.9	0.79	0.75	0.76	0.55	0.83	0.85	0.93	0.94	0.97	0.83	0.16		0.93	0.94	0.93	0.58
Inventory	1.0	0.86	1.0	1.0	0.98	0.99	0.89	-0.08	-0.3	0.92	0.51	0.9	0.85	0.49	0.74	0.74	0.92	0.81	0.94	0.74	0.47	0.93		0.9	0.91	0.82
Other Current Assets	0.89	0.91	0.9	0.9	0.92	0.92	0.97	-0.33	0.06	0.97	0.66	0.69	0.69	0.45	0.82	0.83	0.97	0.95	0.93	0.82	0.14	0.94	0.9		0.96	0.56
Other Stockholder Equity	0.92	0.93	0.9	0.9	0.95	0.95	0.94	-0.31	-0.12	0.96	0.62	0.7	0.69	0.45	0.83	0.86	0.99	0.95	0.9	0.83	0.16	0.93	0.91	0.96		0.57
Total Liab	0.81	0.46	0.83	0.83	0.71	0.72	0.58	0.41	-0.6	0.67	0.02	0.96	0.83	0.3	0.41	0.25	0.61	0.38	0.66	0.41	0.89	0.58	0.82	0.56	0.57

Click cells to compare fundamentals

Inari MedicalInc Account Relationship Matchups

Inari MedicalInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	44.5M	214.1M	311.5M	504.2M	674.2M	707.9M
Other Current Liab	6.3M	10.8M	35.2M	47.2M	64.1M	67.3M
Total Current Liabilities	8.9M	13.8M	42.5M	56.2M	76.3M	80.2M
Total Stockholder Equity	(39.1M)	200.3M	239.2M	417.0M	464.9M	488.2M
Net Tangible Assets	(39.1M)	200.3M	239.2M	417.0M	479.6M	503.5M
Property Plant And Equipment Net	3.3M	7.5M	61.4M	72.4M	69.3M	39.4M
Net Debt	(4.2M)	(114.2M)	(63.5M)	(27.9M)	(7.2M)	(7.5M)
Retained Earnings	(41.2M)	(27.4M)	(17.6M)	(46.9M)	(48.5M)	(50.9M)
Accounts Payable	2.5M	3.0M	6.5M	7.7M	10.6M	5.7M
Cash	23.6M	114.2M	92.8M	60.2M	39.2M	64.5M
Non Current Assets Total	5.1M	8.4M	66.3M	81.2M	438.7M	460.6M
Non Currrent Assets Other	1.5M	583K	981K	589K	2.2M	2.3M
Other Assets	1.8M	921K	981K	589K	677.4K	949.3K
Cash And Short Term Investments	23.6M	164.2M	176.1M	326.4M	116.1M	151.8M
Net Receivables	11.3M	28.0M	42.4M	58.6M	70.1M	39.0M
Common Stock Shares Outstanding	48.2M	51.6M	55.6M	52.8M	56.8M	56.8M
Liabilities And Stockholders Equity	44.5M	214.1M	311.5M	504.2M	674.2M	707.9M
Non Current Liabilities Total	74.8M	3.0M	29.8M	31.0M	133.0M	139.6M
Inventory	4.0M	10.6M	21.1M	32.6M	42.9M	45.0M
Other Current Assets	514.1K	2.9M	5.7M	5.3M	6.5M	4.0M
Other Stockholder Equity	2.1M	227.6M	257.1M	462.9M	504.5M	266.9M
Total Liab	83.7M	13.8M	72.3M	87.2M	209.3M	219.8M
Net Invested Capital	(19.7M)	200.3M	239.2M	417.0M	464.9M	233.2M
Property Plant And Equipment Gross	3.3M	7.5M	61.4M	72.4M	83.0M	41.9M
Total Current Assets	39.4M	205.7M	245.2M	422.9M	235.6M	215.4M
Accumulated Other Comprehensive Income	(54.2M)	4K	(402K)	849K	8.9M	9.3M
Capital Stock	6.7K	49K	50K	54K	58K	41.1K
Net Working Capital	30.5M	191.8M	202.7M	366.7M	159.2M	178.7M
Common Stock	6.7K	49K	50K	54K	58K	41.1K
Property Plant Equipment	3.3M	7.5M	16.5M	72.4M	83.2M	87.4M

Currently Active Assets on Macroaxis

V	Visa Class A
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Inari MedicalInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari MedicalInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medicalinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medicalinc Stock:

How To Invest In Inari

Details

Is Inari Stock a good investment?

Details

What is Inari MedicalInc's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari MedicalInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Inari Stock please use our How to Invest in Inari MedicalInc guide.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Inari Stock analysis

When running Inari MedicalInc's price analysis, check to measure Inari MedicalInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari MedicalInc is operating at the current time. Most of Inari MedicalInc's value examination focuses on studying past and present price action to predict the probability of Inari MedicalInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari MedicalInc's price. Additionally, you may evaluate how the addition of Inari MedicalInc to your portfolios can decrease your overall portfolio volatility.

	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Inari MedicalInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari MedicalInc. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari MedicalInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.84)

Earnings Share

(0.41)

Revenue Per Share

9.045

Quarterly Revenue Growth

0.233

Return On Assets

(0.01)

The market value of Inari MedicalInc is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari MedicalInc's value that differs from its market value or its book value, called intrinsic value, which is Inari MedicalInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari MedicalInc's market value can be influenced by many factors that don't directly affect Inari MedicalInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inari MedicalInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari MedicalInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari MedicalInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inari Ebitda vs Selling And Marketing Expenses Analysis

Ebitda vs Selling And Marketing Expenses

Ebitda vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Ebitda

Selling And Marketing Expenses

Inari MedicalInc fundamental ratios Correlations

Inari MedicalInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inari MedicalInc fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Inari Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Inventory	+ 1.0	Other Current Liab
Inventory	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Long Term Debt Total	+ 1.0	Long Term Debt

Cash	- 0.88	Net Debt
Retained Earnings	- 0.72	Net Debt
Non Current Liabilities Total	- 0.71	Retained Earnings
Total Liab	- 0.6	Retained Earnings
Common Stock Total Equity	- 0.57	Net Debt
Net Debt	- 0.49	Short Long Term Debt Total